Amylyx Pharmaceuticals Inc AMLX

$30.29 +0.43 (1.44%)

Valuation

Market cap
3,838,891,000
Revenue TTM
$0
Net income TTM
$-144,740,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
1,618,600
Avg volume
1,408,082
Day's range
$28.85 – $30.72
Shares out
128,563,000
Stochastic %K
64%
Beta
-0.09
Analysts
Strong Buy
Price target
$39.67

Price

Company profile

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsu...

Show more

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
617 682 0917
Website
https://amylyx.com
Address
55 Cambridge Parkway, Suite 6W, Cambridge, United States

Latest news

Stocktwits

ajmore Nov 13, 6:33 AM
$AMLX Eyes on the ball; window dressing starting soon, als conf, investors conferences, the fda filing, a xbi bad day will not stop our momentum.
0 replies
Papermoon347 Nov 12, 3:15 PM
$AMLX reverse already need xbi
0 replies
LoveRetailFroth Nov 12, 2:27 PM
$RXRX Good Morning ☕️☕️☕️😂 $AMLX $ARBE $PRQR
0 replies
TBarrett Nov 11, 6:37 PM
$AMLX $ARBE $RXRX $SMMT
0 replies
LoveRetailFroth Nov 11, 4:28 PM
$ARBE Good Morning Folks ☕️ $RXRX $AMLX $SMMT
0 replies
Papermoon347 Nov 11, 3:18 PM
$AMLX would be nice if we close above 31.50
1 replies
HarrisMint Nov 11, 12:12 PM
$AMLX Heavy near-term resistance about 31.5x area. Might run puts off that level.
0 replies
LoveRetailFroth Nov 10, 8:51 PM
$AMLX $60 EOY 🚀
0 replies